Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,035 shares at $28.96 ($146K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $146k AGIO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.96 | 594 | $17K | 11.8% |
| 2 | $28.96 | 1,187 | $34K | 23.6% |
| 3 | $28.96 | 1,573 | $46K | 31.2% |
| 4 | $28.96 | 1,681 | $49K | 33.4% |
| Total | $28.96 avg | 5,035 | $146K | 100% |
| Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $141K | — | Filing → |